EWTX filings
Corporate insider profile
Kevin Koch Filing Activity
Latest reported as President and CEO of Edgewise Therapeutics, Inc. (EWTX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$785,041.57
- Latest transaction
- Aug 12, 2026
Affiliated corporations
Reported company relationships
Transaction history
